These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16144886)

  • 1. Summaries for patients. Tiotropium and the treatment of chronic obstructive lung disease.
    Ann Intern Med; 2005 Sep; 143(5):I20. PubMed ID: 16144886
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
    Niewoehner DE; Rice K; Cote C; Paulson D; Cooper JA; Korducki L; Cassino C; Kesten S
    Ann Intern Med; 2005 Sep; 143(5):317-26. PubMed ID: 16144890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J; Fehér J
    Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium.
    O'Connor AB
    Ann Intern Med; 2006 Jan; 144(2):148; author reply 148-9. PubMed ID: 16418423
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium.
    Good CB; Longo L
    Ann Intern Med; 2006 Jan; 144(2):147; author reply 148-9. PubMed ID: 16418422
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
    Ma J; Zhou Z; Tang Y; Zhong N
    Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.
    Cooper CB; Anzueto A; Decramer M; Celli B; Tashkin DP; Leimer I; Kesten S
    Int J Chron Obstruct Pulmon Dis; 2011; 6():269-75. PubMed ID: 21845038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
    McIvor RA
    Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-edged sword?
    Woodruff PG
    JAMA Intern Med; 2013 Jul; 173(13):1184-5. PubMed ID: 23689337
    [No Abstract]   [Full Text] [Related]  

  • 10. Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.
    Rau-Berger H; Mitfessel H; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():367-73. PubMed ID: 21103403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.
    Hsu JY; Perng RP; Lu JY; Wu CP; Huang MS; Luh KT; Yang PC
    J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
    Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
    Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.
    Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S
    Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD.
    Hodder R; Pavia D; Lee A; Bateman E
    Int J Chron Obstruct Pulmon Dis; 2011; 6():245-51. PubMed ID: 21814460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease.
    Hohlfeld JM; Sharma A; van Noord JA; Cornelissen PJ; Derom E; Towse L; Peterkin V; Disse B
    J Clin Pharmacol; 2014 Apr; 54(4):405-14. PubMed ID: 24165906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 17. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].
    Ohmura T; Nishikawa H
    Nihon Yakurigaku Zasshi; 2005 May; 125(5):307-13. PubMed ID: 15997169
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety, tolerability and risk benefit analysis of tiotropium in COPD.
    Oba Y; Zaza T; Thameem DM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):575-84. PubMed ID: 19281075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term bronchodilator inhaled therapy in COPD: the role of tiotropium bromidum.
    Antoniu SA
    Rev Recent Clin Trials; 2009 May; 4(2):89-98. PubMed ID: 19463105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.